SA PRO
Free Account
Caris Life Sciences, Inc.CAINYSE
LOADING
|||
Switch Symbol:
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 75% recommend buying.

Consensus Rating
Buy
4 analysts·Low coverage
75%
Rating Distribution
Strong Buy
00%
Buy
375%
Hold
125%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 62% higher.

Bear Case
$30.00
+29%
Consensus
$37.67
+62%
Bull Case
$45.00
+94%
Price Range4 analysts
Low
Consensus
High
$30.00
$45.00
Current Target
Current Price
$23.20
Upside to Target
$14.47

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Earnings Surprises

Recent Analyst Actions

Jan 5, 2026Evercore ISI
Caris Life Sciences price target lowered to $38 from $40 at Evercore ISI
Target:$38.00
+42.5%from $26.68
Dec 22, 2025Canaccord Genuity
Caris Life Sciences price target raised to $30 from $28 at Canaccord
Target:$30.00
+7.4%from $27.94
Dec 2, 2025Canaccord Genuity
Caris Life Sciences initiated with a Hold at Canaccord
Target:$28.00
+7.5%from $26.05
Aug 13, 2025BTIG
Caris Life Sciences price target raised to $45 from $38 at BTIG
Target:$45.00
+29.4%from $34.78
Jul 13, 2025Guggenheim
Caris Life Sciences initiated with a Buy at Guggenheim
Target:$32.00
+20.7%from $26.51

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance